Structure–activity relationship studies of new rifamycins containing l -amino acid esters as inhibitors of bacterial RNA polymerases

European Journal of Medicinal Chemistry
2016.0

Abstract

New rifamycins (1-12) combined with different l-amino acids, containing methyl, ethyl, tert-butyl and benzyl groups at the ester part, via amine linkage, were synthesized and their structures in solution were determined by spectroscopic FT-IR and 1D and 2D NMR methods as well as visualized by DFT calculations. Two types of rifamycin structures were detected in solution: a zwitterionic one with the transferred proton from O(8)H phenol to secondary N(38) atom and a pseudocyclic structure stabilized via formation of intramolecular H-bond within the protonated basic C(3)-substituent. The presence of these rifamycins' structures influenced physico-chemical (logP, solubility) parameters and antibacterial properties. The bulkiness at the ester substituent of new rifamycins containing aromatic l-amino acids was found to be an important factor, besides the solubility, to achieve relatively high antibacterial activity against reference S. epidermidis and reference S. aureus and MRSA strains (MICs 0.016-0.063 μg/mL), comparable to that of rifampicin. SAR for the novel derivatives was discussed in view of the calculated structures of rifamycin-RNAP complexes.

Knowledge Graph

Similar Paper

Structure–activity relationship studies of new rifamycins containing l -amino acid esters as inhibitors of bacterial RNA polymerases
European Journal of Medicinal Chemistry 2016.0
Synthesis, docking and antibacterial studies of more potent amine and hydrazone rifamycin congeners than rifampicin
European Journal of Medicinal Chemistry 2019.0
The effect of complexation of 3-formylrifamycin SV macrocyclic ether derivatives with metal cations and small nitrogen-containing organic molecules on antibacterial activity against S. aureus and S. epidermidis
Bioorganic & Medicinal Chemistry Letters 2015.0
Synthesis and antibacterial activity of some esters, amides, and hydrazides of 3-carboxyrifamycin S. Relationship between structure and activity of ansamycins
Journal of Medicinal Chemistry 1981.0
Synthesis and structure–activity relationships of novel substituted 8-amino, 8-thio, and 1,8-pyrazole congeners of antitubercular rifamycin S and rifampin
Bioorganic & Medicinal Chemistry Letters 2011.0
X-ray Crystal Structures of the Escherichia coli RNA Polymerase in Complex with Benzoxazinorifamycins
Journal of Medicinal Chemistry 2013.0
Synthesis and biological activity of some derivatives of rifamycin P
Journal of Medicinal Chemistry 1990.0
Structure-Based Design of Novel Benzoxazinorifamycins with Potent Binding Affinity to Wild-Type and Rifampin-Resistant Mutant Mycobacterium tuberculosis RNA Polymerases
Journal of Medicinal Chemistry 2012.0
Comprehensive Study on Structure−Activity Relationships of Rifamycins:  Discussion of Molecular and Crystal Structure and Spectroscopic and Thermochemical Properties of Rifamycin O
Journal of Medicinal Chemistry 1998.0
ISOLATION AND STRUCTURE OF RIFAMYCIN L AND ITS BIOGENETIC RELATIONSHIP WITH OTHER RIFAMYCINS
The Journal of Antibiotics 1969.0